Medicine and Dentistry
Radiation Therapy
100%
Pancreas Cancer
81%
Pancreas Adenocarcinoma
81%
Neoplasm
78%
Overall Survival
56%
Hepatocellular Carcinoma
38%
Computer Assisted Tomography
36%
Chemoradiotherapy
34%
Biological Marker
29%
Diseases
28%
Cholangiocarcinoma
27%
Stereotactic Body Radiation Therapy
26%
Surgery
25%
Malignant Neoplasm
25%
Neoadjuvant Therapy
15%
Intensity Modulated Radiation Therapy
14%
Metastatic Carcinoma
14%
Pancreaticoduodenectomy
14%
Pelvis
14%
Proton Therapy
13%
Gemcitabine
12%
Pancreatectomy
12%
Paclitaxel
12%
Anal Cancer
11%
Re-Irradiation
11%
Oncology
11%
Radiation Oncology
11%
Intraductal Papillary Mucinous Tumor
11%
Recurrent Disease
11%
Hazard Ratio
11%
Cancer
10%
Magnetic Resonance Imaging
10%
Systemic Therapy
10%
Rectum Cancer
10%
Radiomics
10%
Arm
10%
Clinical Trial
10%
Quality of Life
9%
Progression Free Survival
9%
Adenocarcinoma
9%
Image-Guided Intervention
9%
Proportional Hazards Model
9%
Solid Malignant Neoplasm
8%
Squamous Cell Carcinoma
8%
Brain Metastasis
8%
Cancer Therapy
8%
Patient-Reported Outcome
8%
Rectum Carcinoma
8%
Immunotherapy
8%
Survival Rate
7%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
45%
Pancreas Cancer
38%
Overall Survival
35%
Pancreas Adenocarcinoma
33%
Chemotherapy
29%
Liver Cell Carcinoma
25%
Chemoradiation Therapy
24%
Malignant Neoplasm
22%
Paclitaxel
17%
Biological Marker
16%
Diseases
13%
Gemcitabine
11%
Bile Duct Carcinoma
8%
Clinical Trial
8%
Squamous Cell Carcinoma
8%
Progression Free Survival
7%
Immune Checkpoint Inhibitor
7%
Liver Cancer
6%
Solid Malignant Neoplasm
6%
Recurrent Disease
6%
Immunotherapy
6%
Breast Cancer
5%
Dosimetry
5%
Vascular Tumor
5%
Nanoparticle
5%
Keyphrases
Pancreatic Ductal Adenocarcinoma
20%
Radiation Therapy
18%
Pancreatic Cancer
16%
Intrahepatic Cholangiocarcinoma (iCCA)
15%
Radiotherapy
14%
Hepatocellular Carcinoma
13%
Tumor
11%
Overall Survival
11%
Chemoradiation
9%
Chemotherapy
8%
Systemic Therapy
7%
Pancreaticoduodenectomy
7%
Liver
6%
United States
6%
Imaging Biomarkers
6%
Locally Advanced
5%